Dr Richard Harbottle, currently a Research Fellow at the National Heart and Lung Institute at Imperial College London and a founding member of the British Society for Gene Therapy, is one of the leading innovators in gene therapy research. Here he describes his work on developing a gene therapy to treat BHD syndrome.
Your resource for Birt-Hogg-Dubé Syndrome